We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Collaboration to Advance Hematology Diagnostics

By HospiMedica staff writers
Posted on 04 Feb 2004
An alliance to develop new, clinically important hematology diagnostics has been announced by Bio-Reference Laboratories, Inc. More...
(Elmwood Park, NJ, USA) and Sysmex America, Inc. (Mundelein, IL, USA).

Bio-Reference is a large, independent regional clinical laboratory in the northeastern U.S. with a specialized cancer pathology and molecular diagnostics unit called GenPath. Sysmex is a leading diagnostic instrument manufacturer and information systems developer. Bio-Reference believes that Sysmex's innovation and technical superiority can help the company identify and validate new hematology diagnostics. Sysmex was the first company to develop an approved automated measurement of immature granulocytes, the first to automate nucleated red blood cells, using fluorescent flow cytometry, and the first to bring the diode laser to hematology.

"Sysmex America's innovation and technical superiority have resulted in a ‘best of breed' philosophy that has produced a hematology product offering known for its high quality and the introduction of clinically important new parameters,” said Marc D. Grodman, M.D., president and CEO of Bio-Reference Labs. "This is the type of partner that Bio-Reference Laboratories seeks in order to provide its physician-customers with competitive, world-class diagnostics.”




Related Links:
Bio-Reference
Sysmex

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
POC Immunoassay Analyzer
Procise DX
New
Gastrointestinal Panel
Xpert® GI Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Adobe Stock

Blood Biomarkers Help Assess Growth Risks During Steroid Treatment in Duchenne Muscular Dystrophy

Children with Duchenne muscular dystrophy (DMD) commonly receive long-term corticosteroids to slow disease progression, but these drugs can impair linear growth and weaken bone. Understanding how specific... Read more

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.